Status:
UNKNOWN
Determination of COVID-19 Related Virus in Central Nervous System
Lead Sponsor:
IRCCS San Raffaele
Conditions:
COVID-19 Testing
CNS Disease
Eligibility:
All Genders
18+ years
Brief Summary
Coronavirus disease 2019 (COVID-19) is a highly infectious pandemic disease caused by SARS-CoV-2 virus. Central Nervous System (CNS) complications associated with COVID-19 might be secondary sequelae ...
Detailed Description
Determination of SARS-CoV-2 presence in central nervous system
Eligibility Criteria
Inclusion
- Adult patients
- Patients candidate for CNS surgery
- Patients who have been tested for nasopharyngeal swab for SARS-CoV-2
- Patients who have been tested for serology test for anti SARS-CoV-2 immunoglobulinG (IgG) and immunoglobulinM (IgM) antibodies
- Patients able to sign informed consent
Exclusion
- Patients not meeting inclusion criteria
Key Trial Info
Start Date :
December 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04775784
Start Date
December 17 2020
End Date
December 31 2023
Last Update
April 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IRCCS San Raffaele Scientific Institute
Milan, Italy, 20132